ספייק-וקס
medison pharma ltd - cx-024414 mrna - cx-024414 mrna 1.26 mg/vial - covid-19 vaccines
פולידין תרחיץ
fischer pharmaceuticals ltd - povidone-iodine - תמיסה - חיצוני - povidone-iodine 7.5 %w/v - povidone-iodine - povidone-iodine - wound disinfection to prevent skin infections caused by bacteria and fungi, disinfection of infected skin conditions and sidinfection of the hands before medical procedures.
פרסקו טבליות
rekah pharmaceutical industry ltd, israel - calcium carbonate; magnesium carbonate - טבליות לעיסות - calcium carbonate 500 mg; magnesium carbonate 12 mg - calcium carbonate - calcium carbonate - antacid.
פולידין משחה
fischer pharmaceuticals ltd - povidone-iodine - משחה - povidone-iodine 10 %w/w - povidone-iodine - povidone-iodine - for the disinfection of skin infections , wounds and superficial burns.
פן-רפא וי-ק פורטה
rafa laboratories ltd - phenoxymethylpenicillin as potassium - אבקה להכנת סירופ - phenoxymethylpenicillin as potassium 250 mg / 5 ml - phenoxymethylpenicillin - phenoxymethylpenicillin - treatment of infections caused by susceptible micro-organisms.
פן-רפא וי-ק 500
rafa laboratories ltd - phenoxymethylpenicillin as potassium - קפליות - phenoxymethylpenicillin as potassium 500 mg - phenoxymethylpenicillin - phenoxymethylpenicillin - for susceptible microorganisms. to treat group a haemolytic infections of the upper respiratory tract using a twice daily regimen (1 g. bid in adults, 0.5 mg bid in children).
יירבוי 5 מגמל
bristol, myers squibb (israel) limited, israel - ipilimumab - תרכיז להכנת תמיסה לאינפוזיה - ipilimumab 5 mg/ml - ipilimumab - ipilimumab - yervoy (ipilimumab) is indicated for the treatment of unresectable or metastatic melanoma.
לוותרים תמיסה
trima israel pharmaceutical products maabarot ltd - levetiracetam - תמיסה (פומי) - levetiracetam 100 mg/ml - levetiracetam - levetiracetam - levetrim solution is indicated as:- monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. - adjunctive therapy:in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy
דואודופה
abbvie biopharmaceuticals ltd, israel - carbidopa as monohydrate; levodopa - ג'ל - levodopa 20 mg/ml; carbidopa as monohydrate 5 mg/ml - levodopa - levodopa - treatment of advanced levodopa-responsive parkinson's disease with severe motor fluctuations and hyper-/dyskinesia when available combinations of parkinson medicinal products have not given satisfactory results. a positive test of the clinical response to duodopa administered via a temporary nasoduodenal tube is required before a permanent tube is inserted.